目的探讨文迪雅(罗格列酮)对糖耐量减低(impaired glucose tolerance,IGT)或空腹血糖损害(impaired fasting glucose,IFG)(糖稳态受损)患者临床干预治疗的效果。

• objective To investigate the clinical effect of rosiglitazone in the patients with impairedglucose tolerance(IGT) or impaired fasting glucose(IFG).